Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
14.82
+0.01 (0.07%)
At close: Apr 28, 2026, 4:00 PM EDT
14.87
+0.05 (0.34%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Viatris Employees
Viatris had 30,000 employees as of December 31, 2025. The number of employees decreased by 2,000 or -6.25% compared to the previous year.
Employees
30,000
Change (1Y)
-2,000
Growth (1Y)
-6.25%
Revenue / Employee
$476,663
Profits / Employee
-$117,163
Market Cap
17.26B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30,000 | -2,000 | -6.25% |
| Dec 31, 2024 | 32,000 | -6,000 | -15.79% |
| Dec 31, 2023 | 38,000 | 1,000 | 2.70% |
| Dec 31, 2022 | 37,000 | 0 | - |
| Dec 31, 2021 | 37,000 | -8,000 | -17.78% |
| Dec 31, 2020 | 45,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 33,950 |
| Dr. Reddy's Laboratories | 27,811 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
VTRS News
- 15 days ago - Viatris to Report First Quarter 2026 Financial Results on May 7, 2026 - PRNewsWire
- 18 days ago - Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting - PRNewsWire
- 4 weeks ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 5 weeks ago - Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD) - PRNewsWire
- 5 weeks ago - Viatris Transcript: Investor update - Transcripts
- 5 weeks ago - Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030 - PRNewsWire
- 6 weeks ago - Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research - Reuters
- 2 months ago - These S&P 500 stocks are falling the hardest on Tuesday - Market Watch